On the afternoon of May 1, 2026, the Vietnam Food Administration (Ministry of Health) officially requested Quang Tri's health authorities... Read more
Category: Uncategorized
Cardioline Acquires Cardios to Strengthen Global Cardiac Diagnostic Ecosystem
Cardioline, a leader in cardiac diagnostics and telecardiology, has announced the acquisition of Cardios, a Brazil-based innovator in Holter monitoring... Read more
Ray Therapeutics Secures EMA PRIME Status for Vision-Restoring Gene Therapy
Ray Therapeutics has reached a pivotal regulatory milestone as its lead candidate, RTx-015, was granted Priority Medicines (PRIME) designation by... Read more
Chiesi Expands Rare Disease Leadership with $1.9B KalVista Acquisition
Chiesi has announced the largest acquisition in its 90-year history, agreeing to purchase KalVista Pharmaceuticals for approximately $1.9 billion. This... Read more
BMS: High Expectations for Next-Gen Blockbusters Amid Patent Cliff Hurdles
Bristol Myers Squibb (BMS) is generating investor buzz with its late-stage pipeline despite a modest Q1 2026 financial performance. The... Read more
Eli Lilly Lifts 2026 Guidance Following Dominant Q1 Performance
Eli Lilly started the 2026 fiscal year with record-breaking numbers, driven by surging demand for its obesity and diabetes portfolio.... Read more
Merck’s $6.7B Acquisition of Terns: Strategic Diligence Saves $1B
During its Q1 2026 earnings call, Merck & Co. executives detailed the strategic rationale behind the acquisition of Terns Pharmaceuticals,... Read more
Biotech IPO Surge: Hemab and Seaport Raise Combined $556M
The biotech sector's financial momentum continues to accelerate as Hemab Therapeutics and Seaport Therapeutics made their Wall Street debuts in... Read more
Proposed Enhanced Security for Mandatory Psychiatric Treatment: 3-Layer Doors and 24/7 Surveillance
The Ministry of Health has recently proposed a draft Decree aimed at strengthening the management of individuals under mandatory psychiatric... Read more









